Newsfeeds - Spark Newswire

1 minute read

Amarin Posts Encouraging Vascepa Data In Patients With Peripheral Artery Disease

Today, 4:58 PM

Amarin Corporation plc (NASDAQ:AMRN) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The investigators…

AMRN

1 minute read

Watching Amarin Shares; DealReporter Says Activist Investor May Be Pushing For Sale

By Benzinga Newsdesk

Today, 4:58 PM

-Financial Times' DealReporter

AMRN

4 minute read

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

By Shanthi Rexaline

Today, 4:58 PM

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.

ACRX

2 minute read

Earnings

Amarin Corp Earnings Perspective: Return On Capital Employed

By Benzinga Insights

Today, 4:58 PM

Amarin Corp (NASDAQ:AMRN) brought in sales totaling $142.04 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 249.01%, resulting in a loss of $13.07 million.

AMRN

1 minute read

Amarin Corp Q3 EPS $0.03 Beats $(0.03) Estimate, Sales $142.04M Miss $161.96M Estimate

By Bill Haddad

Today, 4:58 PM

Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.03) by 200 percent. This is a 250 percent increase over losses of $(0.02) per share from the same

AMRN

25 minute read

Earnings Scheduled For November 3, 2021

By Benzinga Insights

Today, 4:58 PM

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.

AAWW

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 4:58 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

1 minute read

Media

Cramer Shares His Thoughts On Dynavax, Nucor And Amarin

By Craig Jones

Today, 4:58 PM

On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories.

AMRN

3 minute read

News

Amarin Outlines New Go-To-Market Strategy To Accelerate VASCEPA Growth In US

By Benzinga Newsdesk

Today, 4:58 PM

Amarin Corporation plc (NASDAQ:AMRN) today outlined its new Go-to-Market strategy to accelerate growth of VASCEPA® (icosapent ethyl) in the United States, which focuses on expanding healthcare professional engagement

AMRN

11 minute read

Penny Stocks

TENX: Second Quarter Results

By Zacks Small Cap Research

Today, 4:58 PM

By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT

AMRN